CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands		Sep. 30, 2023	Dec. 31, 2022
Cash and cash equivalents		$ 138,591	$ 264,600
Non-Agency RMBS, at fair value (net of allowance for credit losses of $16 million and $7 million, respectively)		1,024,609	1,147,481
Agency MBS, at fair value		127,706	430,944
Loans held for investment, at fair value		11,426,932	11,359,236
Accrued interest receivable		72,815	61,768
Other assets		96,764	133,866
Derivatives, at fair value		0	4,096
Total assets	[1]	12,887,417	13,401,991
Liabilities:
Secured financing agreements ($3.7 billion and $4.7 billion pledged as collateral, respectively, and includes $340 million and $374 million at fair value, respectively)		2,603,911	3,434,765
Securitized debt, collateralized by Non-Agency RMBS ($250 million and $276 million pledged as collateral, respectively)		75,819	78,542
Securitized debt at fair value, collateralized by Loans held for investment ($11.0 billion and $10.0 billion pledged as collateral, respectively)		7,598,721	7,100,742
Payable for investments purchased		6,237	9,282
Accrued interest payable		35,670	30,696
Dividends payable		49,881	64,545
Accounts payable and other liabilities		22,721	16,616
Total liabilities	[1]	10,392,960	10,735,188
Commitments and Contingencies (See Note 15)
Stockholders' Equity:
Common stock: par value $0.01 per share; 500,000,000 shares authorized, 232,190,087 and 187,226,081 shares issued and outstanding, respectively		2,268	2,318
Additional paid-in-capital		4,291,775	4,318,388
Accumulated other comprehensive income		181,227	229,345
Cumulative earnings		4,134,502	4,038,942
Cumulative distributions to stockholders		(6,115,687)	(5,922,562)
Total stockholders' equity		2,494,457	2,666,803
Total liabilities and stockholders' equity		12,887,417	13,401,991
Variable Interest Entities, Primary Beneficiary
Non-Agency RMBS, at fair value (net of allowance for credit losses of $16 million and $7 million, respectively)		249,825	276,030
Loans held for investment, at fair value		10,440,568	9,855,390
Accrued interest receivable		53,602	47,553
Other assets		14,566	20,293
Total assets		10,758,561	10,199,266
Liabilities:
Securitized debt, collateralized by Non-Agency RMBS ($250 million and $276 million pledged as collateral, respectively)		75,819	78,542
Securitized debt at fair value, collateralized by Loans held for investment ($11.0 billion and $10.0 billion pledged as collateral, respectively)		7,236,558	6,673,917
Accrued interest payable		23,421	17,427
Accounts payable and other liabilities		2,188	2,239
Total liabilities		7,337,986	6,772,125
Series A Preferred Stock
Stockholders' Equity:
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized:		58	58
Series B Preferred Stock
Stockholders' Equity:
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized:		130	130
Series C Preferred Stock
Stockholders' Equity:
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized:		104	104
Series D Preferred Stock
Stockholders' Equity:
Preferred Stock, par value of $0.01 per share, 100,000,000 shares authorized:		$ 80	$ 80

[1] The Company's consolidated statements of financial condition include assets of consolidated variable interest entities, or VIEs, that can only be used to settle obligations and liabilities of the VIE for which creditors do not have recourse to the primary beneficiary (Chimera Investment Corporation). As of September 30, 2023, and December 31, 2022, total assets of consolidated VIEs were $10,758,561 and $10,199,266, respectively, and total liabilities of consolidated VIEs were $7,337,986 and $6,772,125, respectively. See Note 8 for further discussion.